Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide for Binge Eating in Obese and Overweight Subjects
NCT01739049Phase 4Completed
- Sponsor
- Hospital Canselor Tuanku Muhriz
- Start
- Nov 2012
- Primary completion
- Oct 2013
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in binge eating disorder (BED), obesity, sponsored by Hospital Canselor Tuanku Muhriz. Started Nov 2012; status: completed.
02
Drugs
03
Conditions
binge eating disorder (BED)obesity
Beyond the preview
Go deeper on NCT01739049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01739049.